Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald J Buchsbaum

Showing results (121-130 of 157) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancerLeo Christopher DeRosier, Donald J Buchsbaum, Patsy G Oliver, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 15, 2015
Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974Jonathan D Boone, Rebecca C Arend, Bobbi E Johnston, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant gliomaWaleed O Arafat, Donald J Buchsbaum, Jesús Gómez-Navarro, et al.
Cancer Research|October 17, 2008
Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imagingHyunki Kim, Desiree E Morgan, Donald J Buchsbaum, et al.
Clinical & Experimental Metastasis|September 17, 2010
KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse modelLacey R McNally, Danny R Welch, Benjamin H Beck, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Potency and selectivity of a novel pan-RAS inhibitor in 3D bioprinted organoid tumor modelsDaniela De Nobrega, Logan C Eiler, Parmanand Ahirwar, et al.
Oncotarget|May 13, 2017
Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growthTaylor B Turner, Selene Meza-Perez, Angelina Londoño, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancerNichole R Dean, J Robert Newman, Emily E Helman, et al.
Molecular Cancer Therapeutics|December 20, 2007
TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growthLeo Christopher Derosier, Selwyn M Vickers, Kurt R Zinn, et al.
Cancer Research|August 21, 2020
STAT3 and GR Cooperate to Drive Gene Expression and Growth of Basal-Like Triple-Negative Breast CancerMegan E Conway, Joy M McDaniel, James M Graham, et al.
Pageof 16

Showing results (121-130 of 157) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancerLeo Christopher DeRosier, Donald J Buchsbaum, Patsy G Oliver, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 15, 2015
Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974Jonathan D Boone, Rebecca C Arend, Bobbi E Johnston, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant gliomaWaleed O Arafat, Donald J Buchsbaum, Jesús Gómez-Navarro, et al.
Cancer Research|October 17, 2008
Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imagingHyunki Kim, Desiree E Morgan, Donald J Buchsbaum, et al.
Clinical & Experimental Metastasis|September 17, 2010
KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse modelLacey R McNally, Danny R Welch, Benjamin H Beck, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Potency and selectivity of a novel pan-RAS inhibitor in 3D bioprinted organoid tumor modelsDaniela De Nobrega, Logan C Eiler, Parmanand Ahirwar, et al.
Oncotarget|May 13, 2017
Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growthTaylor B Turner, Selene Meza-Perez, Angelina Londoño, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancerNichole R Dean, J Robert Newman, Emily E Helman, et al.
Molecular Cancer Therapeutics|December 20, 2007
TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growthLeo Christopher Derosier, Selwyn M Vickers, Kurt R Zinn, et al.
Cancer Research|August 21, 2020
STAT3 and GR Cooperate to Drive Gene Expression and Growth of Basal-Like Triple-Negative Breast CancerMegan E Conway, Joy M McDaniel, James M Graham, et al.
Pageof 16